Effective and safe proton pump inhibitor therapy in acid-related diseases–a position paper addressing benefits and potential harms of acid suppression
Background The introduction of proton pump inhibitors (PPIs) into clinical practice has
revolutionized the management of acid-related diseases. Studies in primary care and …
revolutionized the management of acid-related diseases. Studies in primary care and …
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy …
Guidelines, Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Dual antiplatelet therapy, Acute
coronary syndromes, Coronary artery bypass grafting, Coronary artery disease, Drug-eluting …
coronary syndromes, Coronary artery bypass grafting, Coronary artery disease, Drug-eluting …
Acid-suppressive therapy and risk of infections: pros and cons
L Fisher, A Fisher - Clinical drug investigation, 2017 - Springer
This narrative review summarises the benefits, risks and appropriate use of acid-
suppressing drugs (ASDs), proton pump inhibitors and histamine-2 receptor antagonists …
suppressing drugs (ASDs), proton pump inhibitors and histamine-2 receptor antagonists …
[HTML][HTML] Deprescribiendo para mejorar la salud de las personas o cuando deprescribir puede ser la mejor medicina
ÓE Jiménez, MPA Aniés, CV Caldentey, FG Rubio… - Atención Primaria, 2018 - Elsevier
La creciente longevidad de la población, el aumento de la morbilidad y del consumo de
medicamentos han provocado que la polimedicación sea un problema de salud prioritario …
medicamentos han provocado que la polimedicación sea un problema de salud prioritario …
Clinical outcomes of anti‐reflux mucosal ablation for gastroesophageal reflux disease: An international bi‐institutional study
Y Shimamura, H Inoue, M Tanabe… - Journal of …, 2024 - Wiley Online Library
Abstract Background and Aim Anti‐reflux mucosal ablation (ARMA) is an emerging
endoscopic treatment aimed at enhancing the gastroesophageal junction flap valve. This …
endoscopic treatment aimed at enhancing the gastroesophageal junction flap valve. This …
Prevalence and risk factors of long-term proton pump inhibitors-associated hypomagnesemia: a cross-sectional study in hospitalized patients
DA Recart, A Ferraris, CI Petriglieri… - Internal and Emergency …, 2021 - Springer
Background Proton pump inhibitors (PPI)-related hypomagnesemia is a potentially life-
threatening adverse event first described in 2006. PPIs are widely used in the general …
threatening adverse event first described in 2006. PPIs are widely used in the general …
[HTML][HTML] Evaluación el síndrome anémico en el adulto mayor
NR Terry Leonard, CA Mendoza Hernández… - Medisur, 2019 - scielo.sld.cu
La anemia es una condición común en el anciano y significa un factor de riesgo por el
incremento de la morbimortalidad en esta etapa de la vida, la cual reduce no solo la …
incremento de la morbimortalidad en esta etapa de la vida, la cual reduce no solo la …
Successful deprescribing of proton pump inhibitors with a patient-centered process: the DESPIBP Project
LLJ Calvo, P García Cámara, M Llorente Barrio… - European Journal of …, 2021 - Springer
Abstract Background Proton-pump inhibitors (PPIs) are among the most frequently
prescribed drugs, but they are being overprescribed. Objective To evaluate the applicability …
prescribed drugs, but they are being overprescribed. Objective To evaluate the applicability …
[HTML][HTML] Enfoque diagnóstico y terapéutico de dispepsia y dispepsia funcional:¿ qué hay nuevo en el 2019?
A Lúquez Mindiola, W Otero Regino… - … de Gastroenterología del …, 2019 - scielo.org.pe
La dispepsia abarca un conjunto de síntomas que se originan en la región gastroduodenal.
Se caracteriza por dolor o ardor epigástrico, saciedad precoz y llenura pos-prandial. Según …
Se caracteriza por dolor o ardor epigástrico, saciedad precoz y llenura pos-prandial. Según …
Proton-pump inhibitors are associated with a high false-positivity rate in faecal immunochemical testing
G Ibáñez-Sanz, N Milà, LC de la Peña-Negro… - Journal of …, 2021 - Springer
Background False-positivity rates in faecal immunochemical test (FIT) can be affected by
drug exposure. We aimed to assess the association between proton pump inhibitors (PPI) …
drug exposure. We aimed to assess the association between proton pump inhibitors (PPI) …